Wyatt McDonnell
Chief Executive Officer & Founding Scientist
Bio:
Dr. Wyatt McDonnell is Co-Founder, CEO, and Chairman of the Board of Directors at Infinimmune, a preclinical antibody biotechnology company treating human disease with truly human antibody therapeutics. Previously, Wyatt worked on world-class single cell technologies at 10x Genomics where he was Technical Lead and Developer of Barcode-Enabled Antigen Mapping (BEAM). Wyatt developed 10x Genomics’ first therapeutic antibodies and core immunology intellectual property behind three commercial products to interrogate the immune repertoire. He has co-authored 42 peer-reviewed papers in journals including Nature, Cell, and Nature Medicine, and 29 published patents. He has been invited to speak at conferences including PEGS, the Keystone Symposia, Antibody Engineering and Therapeutics, the Antibody Series, the World Vaccine Congress, LEAP, and PMWC.